Showing results (1001-1010 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|July 9, 2016
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid TumorsSherri Z Millis, Sadakatsu Ikeda, Sandeep Reddy, et al.JAMA Oncology|September 1, 2017
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical TrialElias Jabbour, Farhad Ravandi, Partow Kebriaei, et al.JAMA Oncology|June 30, 2016
Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic ReviewSasha E Stanton, Sylvia Adams, Mary L DisisJAMA Oncology|November 25, 2020
Regional Adoption of Commercial Gene Expression Testing for Prostate CancerMichael S Leapman, Rong Wang, Shuangge Ma, et al.JAMA Oncology|September 4, 2020
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical TrialKohei Shitara, Eric Van Cutsem, Yung-Jue Bang, et al.JAMA Oncology|October 22, 2020
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A ReviewMatthias Pinter, Rakesh K Jain, Dan G DudaJAMA Oncology|October 22, 2020
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the ProstateRobert T Dess, Krithika Suresh, Michael J Zelefsky, et al.JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.JAMA Oncology|September 10, 2020
Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX TreatmentStijn van Roessel, Eran van Veldhuisen, Sjors Klompmaker, et al.JAMA Oncology|January 19, 2023
Long-term Trajectories of Physical Function Decline in Women With and Without CancerElizabeth M Cespedes Feliciano, Sowmya Vasan, Juhua Luo, et al.Pageof 161